| Financial Year |
March 31 2023 |
| Monetary Funds |
962,795,509.83 |
| Held-for-trading Financial Assets |
279,559,762.71 |
| Notes Receivable |
15,861,658.24 |
| Accounts Receivable |
673,246,344.18 |
| Advances to Suppliers |
31,961,154.17 |
| Other Receivables |
32,818,627.75 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
405,115,508.17 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
557,069,502.54 |
| Other Current Assets |
90,227,705.03 |
| Total Current Assets |
3,693,934,926.19 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
49,694,588.61 |
| Investment Properties |
-- |
| Fixed Assetes |
1,525,200,700.71 |
| Under-construction Projects |
28,899,913.32 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
250,434,067.36 |
| R&D expenses |
-- |
| Goodwill |
237,442,220.12 |
| Long-Term Deferred and Prepaid Expenses |
18,246,276.21 |
| Deferred Income Tax Assets |
20,906,939.32 |
| Other Non-Current Assets |
336,025,785.41 |
| Sub-Total of Non-Current Assets |
2,474,638,382.58 |
| Total Assets |
6,168,573,308.77 |
| Short-Term Loans |
65,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,480,746,075.65 |
| Accounts Payable |
606,235,212.12 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
15,277,005.96 |
| Taxes Payable |
30,023,407.69 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
135,590,579.31 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,579,331.50 |
| Other Current Liabilities |
3,759,628.83 |
| Sub-Total of Current Liabilities |
2,377,006,232.02 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
12,389,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
7,596,449.88 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
77,583,848.64 |
| Total Liabilities |
2,454,590,080.66 |
| Paid-In Capital(Or Share Stock) |
728,000,000.00 |
| Capital Surplus |
191,332,909.04 |
| Surplus Reserve |
220,729,380.90 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
2,400,257,936.22 |
| Minority Stockholder's Interest |
177,532,388.86 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,536,450,839.25 |
| Owner's Equity（Stockholder's Equity） |
3,713,983,228.11 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
6,168,573,308.77 |
